X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (49) 49
index medicus (39) 39
humans (35) 35
sarcoma (32) 32
cancer (26) 26
middle aged (26) 26
female (25) 25
male (25) 25
tumors (25) 25
adult (24) 24
aged (23) 23
chemotherapy (20) 20
aged, 80 and over (15) 15
metastasis (15) 15
patients (15) 15
clinical trials (13) 13
hematology, oncology and palliative medicine (13) 13
prognosis (13) 13
surgery (13) 13
treatment outcome (13) 13
survival (12) 12
retrospective studies (11) 11
analysis (10) 10
disease-free survival (10) 10
metastases (10) 10
soft-tissue sarcoma (10) 10
young adult (10) 10
diagnosis (9) 9
research (9) 9
sarcoma - pathology (9) 9
soft tissue neoplasms - pathology (9) 9
survival rate (9) 9
management (8) 8
solid tumors (8) 8
anthracyclines (7) 7
antineoplastic agents - therapeutic use (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
care and treatment (7) 7
gemcitabine (7) 7
mutation (7) 7
sarcoma - drug therapy (7) 7
sarcoma - mortality (7) 7
adolescent (6) 6
european-organization (6) 6
soft tissue neoplasms - drug therapy (6) 6
therapy (6) 6
tyrosine (6) 6
cancer therapies (5) 5
efficacy (5) 5
follow-up studies (5) 5
france (5) 5
guidelines (5) 5
medical research (5) 5
multivariate analysis (5) 5
prognostic-factors (5) 5
radiation therapy (5) 5
resection (5) 5
risk factors (5) 5
safety (5) 5
sarcoma - therapy (5) 5
toxicity (5) 5
antimitotic agents (4) 4
antineoplastic agents (4) 4
breast cancer (4) 4
databases (4) 4
doxorubicin - therapeutic use (4) 4
follow-up (4) 4
gastrointestinal stromal tumors - pathology (4) 4
health aspects (4) 4
ifosfamide (4) 4
imatinib (4) 4
imatinib mesylate (4) 4
kaplan-meier estimate (4) 4
leiomyosarcoma - mortality (4) 4
leiomyosarcoma - pathology (4) 4
leiomyosarcoma - therapy (4) 4
liposarcoma - mortality (4) 4
medical prognosis (4) 4
medicine & public health (4) 4
medicine, experimental (4) 4
neoplasm metastasis (4) 4
original (4) 4
original articles (4) 4
patient outcomes (4) 4
protein-tyrosine kinase (4) 4
soft tissue neoplasms - therapy (4) 4
soft tissue sarcoma (4) 4
trial (4) 4
1st-line treatment (3) 3
angiogenesis (3) 3
antineoplastic agents - adverse effects (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
apoptosis (3) 3
astronomy & astrophysics (3) 3
bone cancer (3) 3
breast-cancer (3) 3
children (3) 3
combined modality therapy (3) 3
cyclophosphamide (3) 3
data bases (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 12, pp. 1732 - 1742
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 949 - 956
Summary Background Diffuse-type tenosynovial giant cell tumour (dt-GCT) of the soft tissue (alternatively known as pigmented villonodular synovitis), an orphan... 
Hematology, Oncology and Palliative Medicine | PIGMENTED VILLONODULAR SYNOVITIS | DIAGNOSIS | THERAPY | EFFICACY | ONCOLOGY | PERIORBITAL EDEMA SECONDARY | MACROPHAGES | RECEPTOR | ANTIBODY | ARTHRITIS | IMATINIB MESYLATE | Receptor, Macrophage Colony-Stimulating Factor - antagonists & inhibitors | Receptor, Macrophage Colony-Stimulating Factor - immunology | Giant Cell Tumors - immunology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Giant Cell Tumors - pathology | Soft Tissue Neoplasms - drug therapy | Male | Antineoplastic Agents - administration & dosage | Giant Cell Tumors - metabolism | Receptor, Macrophage Colony-Stimulating Factor - metabolism | Synovitis, Pigmented Villonodular - drug therapy | Synovitis, Pigmented Villonodular - pathology | Soft Tissue Neoplasms - immunology | Young Adult | Time Factors | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Drug Administration Schedule | Soft Tissue Neoplasms - metabolism | Synovitis, Pigmented Villonodular - metabolism | Treatment Outcome | Synovitis, Pigmented Villonodular - immunology | Giant Cell Tumors - drug therapy | Signal Transduction - drug effects | Antibodies, Monoclonal - administration & dosage | Adolescent | Soft Tissue Neoplasms - pathology | Aged | Infusions, Intravenous | Monoclonal antibodies | Macrophage colony stimulating factor | Tumors
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 4, pp. 457 - 464
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 5, pp. 632 - 641
Journal Article
Annals of Oncology, ISSN 0923-7534, 2016, Volume 27, Issue 10, pp. 1815 - 1817
Journal Article
European Journal of Surgical Oncology, ISSN 0748-7983, 2017, Volume 43, Issue 6, pp. 1117 - 1125
Journal Article
The Lancet Oncology, ISSN 1470-2045, 05/2018, Volume 19, Issue 5, pp. 649 - 659
Activating enhancer of zeste homolog 2 (EZH2) mutations or aberrations of the switch/sucrose non-fermentable (SWI/SNF) complex (eg, mutations or deletions of... 
OVARY | ACTIVATION | METHYLTRANSFERASE | ONCOLOGY | COMPLEXES | EPITHELIOID SARCOMA | HYPERCALCEMIC TYPE | SMARCA4 MUTATIONS | CARCINOMA | CANCER | MALIGNANT RHABDOID TUMORS | Methylation | Lymphomas | Life Sciences | Cancer
Journal Article
European Journal of Surgical Oncology, ISSN 0748-7983, 2017, Volume 43, Issue 6, pp. 1110 - 1116
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 2011, Volume 22, Issue 2, pp. 268 - 279
Journal Article
Annals of Oncology, ISSN 0923-7534, 06/2016, Volume 27, Issue 6, pp. 1171 - 1172
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 7/2019, Volume 26, Issue 7, pp. 2286 - 2293
Guidelines recommend that retroperitoneal sarcoma (RPS) be managed in a reference sarcoma center (RSC), but the benefit remains to be demonstrated. This study... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | Sarcoma | Analysis | Databases
Journal Article
Annals of oncology : official journal of the European Society for Medical Oncology, ISSN 0923-7534, 06/2019, Volume 30, Issue 8, pp. 1407 - 1407
Journal Article
Journal Article